DD284011A5 - Verfahren zur herstellung der (3r,s)-oder(3r)-form einer verbindung - Google Patents

Verfahren zur herstellung der (3r,s)-oder(3r)-form einer verbindung Download PDF

Info

Publication number
DD284011A5
DD284011A5 DD89330509A DD33050989A DD284011A5 DD 284011 A5 DD284011 A5 DD 284011A5 DD 89330509 A DD89330509 A DD 89330509A DD 33050989 A DD33050989 A DD 33050989A DD 284011 A5 DD284011 A5 DD 284011A5
Authority
DD
German Democratic Republic
Prior art keywords
alkyl
formula
compound
group
groups
Prior art date
Application number
DD89330509A
Other languages
German (de)
English (en)
Inventor
David Alker
Peter E Cross
Robert M Wallis
Original Assignee
������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@���Kk�� filed Critical ������@���Kk��
Publication of DD284011A5 publication Critical patent/DD284011A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DD89330509A 1988-07-08 1989-07-06 Verfahren zur herstellung der (3r,s)-oder(3r)-form einer verbindung DD284011A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888816365A GB8816365D0 (en) 1988-07-08 1988-07-08 Therapeutic agents

Publications (1)

Publication Number Publication Date
DD284011A5 true DD284011A5 (de) 1990-10-31

Family

ID=10640168

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89330509A DD284011A5 (de) 1988-07-08 1989-07-06 Verfahren zur herstellung der (3r,s)-oder(3r)-form einer verbindung

Country Status (28)

Country Link
US (1) US5089505A (sv)
EP (1) EP0350309B1 (sv)
JP (2) JPH0739388B2 (sv)
KR (1) KR930002728B1 (sv)
CN (1) CN1022914C (sv)
AT (1) ATE82262T1 (sv)
AU (1) AU602453B2 (sv)
CA (1) CA1336833C (sv)
DD (1) DD284011A5 (sv)
DE (1) DE68903437T2 (sv)
DK (1) DK337589A (sv)
EG (1) EG18853A (sv)
ES (1) ES2052917T3 (sv)
FI (1) FI94241C (sv)
GB (1) GB8816365D0 (sv)
GR (1) GR3006595T3 (sv)
HU (1) HUT50771A (sv)
IE (1) IE63438B1 (sv)
IL (1) IL90792A0 (sv)
MX (1) MX16728A (sv)
MY (1) MY106976A (sv)
NO (1) NO892828L (sv)
NZ (1) NZ229865A (sv)
PL (2) PL162318B1 (sv)
PT (1) PT91081B (sv)
RU (2) RU1838307C (sv)
YU (1) YU135389A (sv)
ZA (1) ZA895175B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231104A (en) * 1988-07-08 1993-07-27 Pfizer Inc. 1-arylethyl-3-substituted piperidines
GB9000301D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Piperidine & pyrrolidine derivatives
GB9208230D0 (en) * 1992-04-14 1992-05-27 Pfizer Ltd Treatment of delayed gastric emptying
US5340826A (en) * 1993-02-04 1994-08-23 Pfizer Inc. Pharmaceutical agents for treatment of urinary incontinence
GB9400600D0 (en) * 1994-01-14 1994-03-09 Pfizer Ltd Treatment of motion seckness
AU2482100A (en) * 1998-12-18 2000-07-03 Du Pont Pharmaceuticals Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
US6525069B1 (en) 1998-12-18 2003-02-25 Bristol-Myers Squibb Pharma Co. N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
US6331541B1 (en) 1998-12-18 2001-12-18 Soo S. Ko N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
US6492400B1 (en) 1998-12-18 2002-12-10 Bristol-Myers Squibb Pharma Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
JP2002532427A (ja) * 1998-12-18 2002-10-02 デュポン ファーマシューティカルズ カンパニー ケモカイン受容体活性のモジュレーターとしてのn−ウレイドアルキルピペリジン
US6897234B2 (en) 1999-12-17 2005-05-24 Bristol-Myers Squibb Pharma Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
AU2001273129A1 (en) 2000-06-30 2002-01-14 Bristol-Myers Squibb Pharma Company N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity
JP2004509103A (ja) * 2000-09-11 2004-03-25 セプレイコー インコーポレイテッド モノアミン受容体及び輸送体のリガンドならびにその使用方法
US6508872B2 (en) * 2001-02-26 2003-01-21 Hewlett-Packard Company Lightfast additive molecule for inkjet ink
WO2008144602A1 (en) * 2007-05-18 2008-11-27 Auspex Pharmaceuticals, Inc. Deuterated zamifenacin derivatives
US9365553B2 (en) * 2010-05-27 2016-06-14 Aska Pharmaceutical Co., Ltd. Heterocyclic compound and H1 receptor antagonist
CN107129453B (zh) * 2016-02-26 2019-10-11 中国科学院大连化学物理研究所 化合物、毒蕈碱m受体拮抗剂、组合物及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA541598A (en) * 1957-05-28 Levy Joseph N-substituted-4-benzhydryl etherpiperidines and method for obtaining the same
GB688345A (en) * 1951-02-19 1953-03-04 Greenwood And Hughes Ltd Improvements in sanitary liquid traps
US2745837A (en) * 1954-01-21 1956-05-15 Schering Corp Benzhydryl ethers of alkyl piperidinols
GB780027A (en) * 1955-01-20 1957-07-31 Schering Corp 3-piperidyl ethers and thioethers
US2974146A (en) * 1956-02-24 1961-03-07 Lakeside Lab Inc 3-piperidyl benzhydryl ethers
NL237664A (sv) * 1959-04-01

Also Published As

Publication number Publication date
JPH0739388B2 (ja) 1995-05-01
RU1836364C (ru) 1993-08-23
CA1336833C (en) 1995-08-29
MY106976A (en) 1995-08-30
FI893326A (sv) 1990-01-09
DE68903437D1 (de) 1992-12-17
NO892828L (no) 1990-01-09
HUT50771A (en) 1990-03-28
EP0350309A1 (en) 1990-01-10
IL90792A0 (en) 1990-01-18
ES2052917T3 (es) 1994-07-16
JPH07157469A (ja) 1995-06-20
JPH0276851A (ja) 1990-03-16
DE68903437T2 (de) 1993-03-25
GB8816365D0 (en) 1988-08-10
IE892202L (en) 1990-01-08
PT91081A (pt) 1990-02-08
AU602453B2 (en) 1990-10-11
ATE82262T1 (de) 1992-11-15
FI94241B (sv) 1995-04-28
YU135389A (en) 1991-06-30
MX16728A (es) 1993-08-01
NZ229865A (en) 1991-01-29
ZA895175B (en) 1991-02-27
KR930002728B1 (ko) 1993-04-09
US5089505A (en) 1992-02-18
FI94241C (sv) 1995-08-10
CN1039415A (zh) 1990-02-07
DK337589D0 (da) 1989-07-07
IE63438B1 (en) 1995-04-19
RU1838307C (ru) 1993-08-30
PL162318B1 (pl) 1993-09-30
KR900001683A (ko) 1990-02-27
AU3797189A (en) 1990-02-15
FI893326A0 (sv) 1989-07-07
DK337589A (da) 1990-01-09
PT91081B (pt) 1995-01-31
EG18853A (en) 1994-12-30
GR3006595T3 (sv) 1993-06-30
NO892828D0 (no) 1989-07-07
PL161887B1 (pl) 1993-08-31
CN1022914C (zh) 1993-12-01
EP0350309B1 (en) 1992-11-11

Similar Documents

Publication Publication Date Title
DE69014901T2 (de) Muscarin-rezeptor-antagonisten.
DD284011A5 (de) Verfahren zur herstellung der (3r,s)-oder(3r)-form einer verbindung
DE69024663T2 (de) Muscarin-rezeptor-antagonisten
DD292911A5 (de) Verfahren zur herstellung von pyrrolidinderivaten
DE3026201C2 (sv)
DE69630717T2 (de) 1-acyl-3-phenyl-3-(3-piperidinopropyl)piperidinderivate als für den menschlichen nk3-rezeptor selektive antagonisten
CH539630A (de) Verfahren zur Herstellung von Phenoxyaminopropanol-Derivaten
DE69022744T2 (de) Piperidin und pyrrolidin derivate.
DE60006340T2 (de) 2-(3,5-Bis-trifluoromethyl-phenyl)-N-methyl-N-(6-morpholin-4-yl-4-o-tolyl-pyridin-3-yl)-isobutyramid
DE2002840A1 (de) 2,3,5-trisubstit,-2'-Hydroxy-6,7-benzomorphane und Verfahren zu deren Herstellung
CH637934A5 (de) Verfahren zur herstellung neuer derivate von perhydro-aza-heterocyclen.
DE69007126T2 (de) Muscarin-rezeptor-antagonisten.
DE3586411T2 (de) Dopamin-antagoniste.
DE2539907A1 (de) 4a-aryl-cis-decahydroisochinoline und diese verbindungen enthaltende arzneimittel
DE68928045T2 (de) Muscarinrezeptorantagonisten
DE69014903T2 (de) Disubstituierte piperidine und pyrrolidine als anticholinergische mittel.
DE60206068T2 (de) Aralkyltetrahydropyridine, deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
DE69021294T2 (de) Furanderivate.
DE60013418T2 (de) Morpholinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE60036081T2 (de) (1-phenacyl-3-phenyl-3-piperidylethyl)piperidinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
DD284874A5 (de) Verfahren zur herstellung von muscarinrezeptor-antagonisten
DD141156A5 (de) Verfahren zur herstellung von 4a-aryl-octahydro-1h-2-pyrindinen
DD300542A5 (de) Chemische verbindungen
US5932594A (en) Muscarinic receptor antagonists
EP0389425A1 (de) Neue Benzothiopyranylamine

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee